Liraglutide Audit ADA San Francisco 2014 - Poster

Combined liraglutide-insulin therapy is associated with metabolic improvement and insulin dose reduction in commonly prescribed insulin regimens

Piya Sen Gupta1, Ken Y Thong2, Christopher Walton3, Robert EJ Ryder1, on behalf of ABCD liraglutide audit contributors

1City Hospital, Birmingham, UK

2Rockingham General Hospital, Perth, Australia

3Hull Royal Infirmary, Hull, UK

Discipline: 
Diabetes
Clinical taxonomy: 
Treatments for diabetes
Type 2 diabetes mellitus
Resource taxonomy: 
Audit
Posters

Information for HCPs

COVID-19 Information for Healthcare Professionals

ABCD Webinar Series

ABCD Webinars